Skip to content
  • About us
    • About us
    • Executive commitee
    • Board of Directors
    • Scientific advisors
    • Corporate governance
    • ESG
  • myvac
    • myvac – individualized therapeutic vaccines
  • Pipeline
    • Pipeline
    • TG4050
    • TG4070
    • BT-001
    • TG6050
    • Publications and Presentations
    • Clinical trials FAQ
  • Investors
    • Investor Presentation & Contacts
    • Press releases & events
    • Financial Information
    • Stock Information
    • Annual General Meeting
  • Career
  • English
  • French
PHP Toggle Menu

Category: 2025

Transgene Expands myvac® into Non-Small Cell Lung Cancer with TG4070, an Individualized Neoantigen Therapeutic Vaccine

TG4070

Published 22 June 2026
Categorized as 2025, 2025, 2026, 2026, dates, Myvac, Press release

Transgene to Present Preclinical Data on Novel TG-MVA Prophylactic Vaccine Against mpox at the World Congress on Infectious Diseases

MPOX

Published 26 May 2026
Categorized as 2025, 2025, 2026, 2026, Press release

Transgene’s Combined General Meeting of May 22, 2026

AG 2026

Published 22 May 2026
Categorized as 2025, 2025, 2026, 2026, Press release

Availability of Preparatory Documents for the Combined General Meeting of May 22, 2026

AG 2026

Published 4 May 2026
Categorized as 2025, 2025, 2026, 2026, Press release

Transgene Provides Business and Financial Update for Q1 2026

Q1 2026

Published 29 April 2026
Categorized as 2025, 2025, 2026, 2026, Press release

Transgene Completes Patient Randomization in Phase 2 Part of Clinical Trial Evaluating TG4050 in the Adjuvant Treatment of Head and Neck Cancer

TG4050

Published 13 April 2026
Categorized as 2025, 2025, 2026, 2026, Myvac, Press release, TG4050

Transgene to Participate in Upcoming Investor Meetings

Investor meetings

Published 7 April 2026
Categorized as 2025, 2025, 2026, 2026, Press release

2025 Full-year results and business update

link to webcast

Published 24 March 2026
Categorized as 2025, Myvac, TG4050, Webcast, Webcast

Transgene Announces Financial Calendar for 2026

financial calendar 2026

Published 4 February 2026
Categorized as 2025, 2026, Press release

Transgene to Participate in Upcoming Investor Meetings

investors 2026

Published 17 December 2025
Categorized as 2025, Press release

Posts pagination

Page 1 … Page 6 Older posts
Get to know us

About us

myvac

Pipeline

Investors

Partnering

Company

Career

ESG

Suppliers

Contacts

Legal documents

Legal notices

Privacy Policy

Ethics and compliance

Cookie policy

  • About us
    • About us
    • Executive commitee
    • Board of Directors
    • Scientific advisors
    • Corporate governance
    • ESG
  • myvac
    • myvac – individualized therapeutic vaccines
  • Pipeline
    • Pipeline
    • TG4050
    • TG4070
    • BT-001
    • TG6050
    • Publications and Presentations
    • Clinical trials FAQ
  • Investors
    • Investor Presentation & Contacts
    • Press releases & events
    • Financial Information
    • Stock Information
    • Annual General Meeting
  • Career
  • English
  • French
Menu